Medline Inc（MDLN）今日盘中大涨5.47%，引起了市场的广泛关注。
消息面上，Medline作为全球医疗器械巨头，近期在纳斯达克完成了2025年医疗器械行业最大的IPO，同时也是2025年美国最大的IPO。公司成立于1966年，提供约33.5万种医疗外科产品，供应链覆盖95%的美国客户并实现次日送达。招股书显示，Medline在2022年至2024年营收持续增长，从214.48亿美元增至255亿美元，净利润从亏损2500万美元大幅提升至12亿美元。2025年前9个月，公司营收达206亿美元，净利润9.77亿美元，展现出强劲的盈利能力。
Medline的CEO Jim Boyle将公司比作“医疗保健业的Costco”，强调其会员模式、强大供应链和自有品牌战略。市场认为，此次IPO的成功和公司的长期增长潜力是推动股价上涨的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.